Early intervention with the multiple sclerosis treatment Teriflunomide delays the preliminary symptoms of the autoimmune disease, a new study reports. Those who took teriflunomide had a 72% lower risk of experiencing the initial symptoms of MS than those who took a placebo.from Neuroscience News https://ift.tt/ZB94om0
Comments
Post a Comment